Bibliography to Chapter 4

Mick Mulders

  1. Helfand RF et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. Journal of Infectious Diseases, 1997, 175(1): p. 195-9.
  2. Davidkin I et al.. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. Journal of Infect Diseases, 1998, 178:1567-1570.
  3. Dietz V et al. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bulletin of the World Health Organization, 2004, 82:852-857.
  4. Yermalovich et al. Etiology of maculopapular rash in measles and rubella suspected patients from Belarus. PLoS One, 2014, 10:e111541.
  5. Woods CR. False-positive results for immunoglobulin M serologic results: Explanations and examples. Journal of the Pediatric Infectious Disease Society, 2013, 2:87-90.
  6. Vauloup-Fellous C, Grangeot-Keros L. Humoral immune response after primary rubella virus infection and after vaccination. Clinical Vaccine Immunology, 2007;14:644–647.
  7. WHO. Measles and rubella laboratory network: 2007 meeting on use of alternative sampling techniques for surveillance. Weekly Epidemiological Record, 2008, 83(25): 229-232.
  8. Maple PAC. Application of oral fluid assays in support of mumps, rubella and varicella control programs. Vaccines (Basel), 2015, 3(4):988-1003.
  9. Hutse et al. Oral fluid for the serological and molecular diagnosis of measles. International Journal of Infectious Diseases, 2010, 14:e991-e997.
  10. Abernathy E et al. Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. Journal of Clinical Microbiology, 2009, 47: 182-188.
  11. Uzicanin A et al. Dried blood spots on filter paper as an alternative specimen for measles diagnostics: detection of measles immunoglobulin M antibody by a commercial enzyme immunoassay. Journal of Infectious Diseases, 2011, 204:(Suppl 1): S564-S569.
  12. Helfand RF et al. Dried blood spots versus sera for detection of rubella virus-specific immunoglobulin M (IgM) and IgG in samples collected during a rubella outbreak in Peru. Clinical and Vaccine Immunology 2007, 14:1522-1525.
  13. Mercader S et al. Comparison of available methods to elute serum from dried blood spot samples for measles serology. Journal of Virologic Methods, 2006, 137:140-149.
  14. Morgan-Capner P et al. Clinically apparent rubella reinfection with a detectable rubella specific IgM response. British Medical Journal (Clin Res Ed), 1983, 286:1616.
  15. Best JM et al. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. British Medical Journal, 1989, 299:773-775.
  16. Rosen JB et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clinical Infectious Diseases, 2014, 58:1205-1210.
  17. Bellini WJ, Icenogle JP. Measles and rubella viruses, in Manual of Clinical Microbiology, Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, editors. 9th edition, 2007, ASM Press.
  18. Shonhai A et al. Investigation of a measles outbreak in Zimbabwe, 2010: potential of a point of care test to replace laboratory confirmation of suspected cases. Epidemiology and Infection, 2015, 143(16):3442-50.
  19. Warrener L et al. A point-of care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid. Bulletin of the World Health Organization, 2011, 89:675-82.
  20. van den Berg JP et al. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLoS One. 2014; 9(4): e94714. Published online 2014 Apr 11. doi: 10.1371/journal.pone.0094714
  21. Smits GP et al. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clinical and Vaccine Immunology, 2012, Mar;19(3):396-400.
  22. Smits G et al. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS One. 2013; 8(3): e58234. Published online 2013 Mar 8. doi: 10.1371/journal.pone.0058234